BCX 1812

Known as: BCX-1812, BCX1812 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2007
0120012007

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
A direct link between receptor glycosylation and activation following natural ligand interaction has not been observed. Here, we… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
A convergent and versatile racemic total synthesis of the anti-influenza agent BCX-1812 (RWJ-270201) was accomplished on the… (More)
Is this relevant?
Review
2002
Review
2002
The cyclopentane peramivir (BCX-1812, RWJ-270201) is a highly selective inhibitor of influenza A and B virus neuraminidases and a… (More)
Is this relevant?
2002
2002
Our objective was to assess the pharmacokinetics and pharmacodynamics of RWJ-270201 (BCX-1812), an oral neuraminidase inibitor… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2002
2002
Methods have been developed previously for rapid evaluation of compounds for antiviral activity in 96-well microplates, which… (More)
Is this relevant?
2002
2002
Forty-two influenza A and 23 influenza B isolates collected from untreated subjects during the 1999-2000 influenza season in… (More)
Is this relevant?
2002
2002
A-315675 is a novel, pyrrolidine-based compound that was evaluated in this study for its ability to inhibit A and B strain… (More)
Is this relevant?
2002
2002
Zanamivir and oseltamivir, specific inhibitors of influenza virus neuraminidase, have significantly different characteristics in… (More)
Is this relevant?
2002
2002
Several cyclopentane inhibitors of influenza virus neuraminidase that have inhibitory activities in tissue culture similar to… (More)
Is this relevant?
Review
2001
Review
2001
The influenza virus neuraminidase (NA) is important in the pathogenesis of infection and, thus, is an attractive target for… (More)
Is this relevant?